Researcher addresses calls for increased focus on male circumcision, partner reduction programs as part of HIV prevention in Africa

NPR's "News & Notes" on Tuesday included a discussion with Daniel Halperin, a senior research scientist in the Department of Population and International Health at the Harvard School of Public Health, about a recent study that recommended a shift in HIV prevention strategies in Africa toward the promotion of male circumcision and partner reduction programs.

Halperin, a co-author of the study, said, "We're not in any way advocating for the termination of programs that promote condoms, or for HIV testing, or for treating of other sexually transmitted infections, or for abstinence. We feel all those approaches have some value."

He added, "But in terms of really trying to reduce the epidemic, in terms of really trying to bring down the rate of new infections, these approaches appear to have had relatively little impact" compared with partner reduction programs.

Halperin also discussed demand for male circumcision in African countries, the relationship between HIV/AIDS, poverty and gender inequality on the continent, attention in the media to HIV/AIDS issues and a Ugandan program that promotes a reduction in partners (Chideya, "News & Notes," NPR, 5/27).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Sweden becomes first country to meet global HIV targets